Latest Insider Transactions at Modiv Care Inc (MODV)
This section provides a real-time view of insider transactions for Modiv Care Inc (MODV). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of ModivCare Inc to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of ModivCare Inc's insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 15
2022
|
Kenneth Shepard Vice President, CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
77
-3.83%
|
$8,316
$108.79 P/Share
|
Feb 26
2022
|
L Heath Sampson President, CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
317
-6.37%
|
$36,138
$114.01 P/Share
|
Feb 22
2022
|
Jason E Anderson President of ModivCare Home |
BUY
Grant, award, or other acquisition
|
Direct |
903
+30.7%
|
-
|
Feb 14
2022
|
Coliseum Capital Management, LLC |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
619
-0.05%
|
$66,852
$108.32 P/Share
|
Feb 14
2022
|
Coliseum Capital Management, LLC |
BUY
Exercise of conversion of derivative security
|
Indirect |
619
+0.05%
|
-
|
Feb 10
2022
|
Jonathan B Bush SVP, GC and Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
45
-2.61%
|
$4,905
$109.71 P/Share
|
Feb 10
2022
|
Kenneth Shepard Vice President, CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
26
-1.28%
|
$2,834
$109.71 P/Share
|
Feb 10
2022
|
Coliseum Capital Management, LLC |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
725
-0.06%
|
$79,025
$109.71 P/Share
|
Feb 10
2022
|
Coliseum Capital Management, LLC |
BUY
Exercise of conversion of derivative security
|
Indirect |
725
+0.06%
|
-
|
Feb 08
2022
|
Daniel E Greenleaf CEO and President |
BUY
Grant, award, or other acquisition
|
Direct |
9,170
+17.17%
|
-
|
Feb 08
2022
|
L Heath Sampson President, CEO |
BUY
Grant, award, or other acquisition
|
Direct |
2,200
+30.65%
|
-
|
Feb 08
2022
|
Grover N. Wray Chief Human Resources Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,499
+43.6%
|
-
|
Feb 08
2022
|
Jonathan B Bush SVP, GC and Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
476
+21.65%
|
-
|
Feb 08
2022
|
Jason E Anderson President of ModivCare Home |
BUY
Grant, award, or other acquisition
|
Direct |
1,135
+50.0%
|
-
|
Feb 07
2022
|
Kenneth Shepard Vice President, CAO |
BUY
Grant, award, or other acquisition
|
Direct |
970
+32.26%
|
-
|
Feb 07
2022
|
Todd J Carter Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,223
+8.72%
|
-
|
Feb 07
2022
|
Stacy Saal Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,223
+35.22%
|
-
|
Feb 07
2022
|
Richard A Kerley Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,223
+3.21%
|
-
|
Feb 07
2022
|
Rahul D Samant Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,223
+37.48%
|
-
|
Feb 07
2022
|
Leslie V Norwalk Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,223
+7.61%
|
-
|
Feb 07
2022
|
Garth Graham Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,223
+39.52%
|
-
|
Feb 07
2022
|
Frank J Wright Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,223
+7.33%
|
-
|
Feb 07
2022
|
David A Coulter Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,223
+4.89%
|
-
|
Dec 31
2021
|
Rahul D Samant Director |
BUY
Grant, award, or other acquisition
|
Direct |
168
+17.06%
|
$24,864
$148.29 P/Share
|
Dec 31
2021
|
Frank J Wright Director |
BUY
Grant, award, or other acquisition
|
Direct |
90
+0.63%
|
$13,320
$148.29 P/Share
|
Dec 31
2021
|
David A Coulter Director |
BUY
Grant, award, or other acquisition
|
Direct |
168
+0.74%
|
$24,864
$148.29 P/Share
|
Dec 31
2021
|
Stacy Saal Director |
BUY
Grant, award, or other acquisition
|
Direct |
155
+13.12%
|
$22,940
$148.29 P/Share
|
Oct 27
2021
|
Grover N. Wray Chief Human Resources Officer |
BUY
Grant, award, or other acquisition
|
Direct |
440
+50.0%
|
-
|
Sep 30
2021
|
Stacy Saal Director |
BUY
Grant, award, or other acquisition
|
Direct |
123
+12.37%
|
$22,263
$181.62 P/Share
|
Sep 30
2021
|
David A Coulter Director |
BUY
Grant, award, or other acquisition
|
Direct |
137
+0.61%
|
$24,797
$181.62 P/Share
|
Sep 30
2021
|
Frank J Wright Director |
BUY
Grant, award, or other acquisition
|
Direct |
73
+0.51%
|
$13,213
$181.62 P/Share
|
Sep 15
2021
|
Daniel E Greenleaf CEO and President |
BUY
Open market or private purchase
|
Direct |
581
+1.63%
|
$99,932
$172.85 P/Share
|
Sep 07
2021
|
Coliseum Capital Management, LLC |
SELL
Open market or private sale
|
Indirect |
260,000
-16.86%
|
$48,880,000
$188.14 P/Share
|
Aug 12
2021
|
Coliseum Capital Management, LLC |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
200,000
-11.48%
|
$36,400,000
$182.73 P/Share
|
Aug 12
2021
|
Coliseum Capital Management, LLC |
BUY
Exercise of conversion of derivative security
|
Indirect |
200,000
+10.3%
|
-
|
Jun 30
2021
|
Frank J Wright Director |
BUY
Grant, award, or other acquisition
|
Direct |
79
+0.56%
|
$13,430
$170.07 P/Share
|
Jun 30
2021
|
Stacy Saal Director |
BUY
Grant, award, or other acquisition
|
Direct |
99
+11.69%
|
$16,830
$170.07 P/Share
|
Jun 30
2021
|
David A Coulter Director |
BUY
Grant, award, or other acquisition
|
Direct |
146
+0.65%
|
$24,820
$170.07 P/Share
|
May 04
2021
|
Kenneth W. Wilson Chief Operating Officer |
BUY
Payment of exercise price or tax liability
|
Direct |
620
+7.28%
|
$86,180
$139.54 P/Share
|
Apr 28
2021
|
Rahul D Samant Director |
BUY
Grant, award, or other acquisition
|
Direct |
649
+50.0%
|
-
|
Apr 28
2021
|
Stacy Saal Director |
BUY
Grant, award, or other acquisition
|
Direct |
649
+50.0%
|
-
|
Apr 28
2021
|
Garth Graham Director |
BUY
Grant, award, or other acquisition
|
Direct |
649
+50.0%
|
-
|
Mar 31
2021
|
Frank J Wright Director |
BUY
Grant, award, or other acquisition
|
Direct |
91
+0.65%
|
$13,468
$148.12 P/Share
|
Mar 31
2021
|
David A Coulter Director |
BUY
Grant, award, or other acquisition
|
Direct |
169
+0.76%
|
$25,012
$148.12 P/Share
|
Feb 26
2021
|
L Heath Sampson President, CEO |
BUY
Grant, award, or other acquisition
|
Direct |
2,778
+50.0%
|
-
|
Feb 16
2021
|
Coliseum Capital Management, LLC |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
672
-0.04%
|
$114,912
$171.63 P/Share
|
Feb 16
2021
|
Coliseum Capital Management, LLC |
BUY
Exercise of conversion of derivative security
|
Indirect |
672
+0.04%
|
-
|
Feb 14
2021
|
Coliseum Capital Management, LLC |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
619
-0.04%
|
$110,182
$178.53 P/Share
|
Feb 14
2021
|
Coliseum Capital Management, LLC |
BUY
Exercise of conversion of derivative security
|
Indirect |
619
+0.04%
|
-
|
Feb 13
2021
|
Daniel E Greenleaf CEO and President |
SELL
Payment of exercise price or tax liability
|
Direct |
1,179
-3.3%
|
$209,862
$178.53 P/Share
|